Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Cancer Research|January 21, 2006
Activity of the adenoviral E1A deletion mutant dl922-947 in ovarian cancer: comparison with E1A wild-type viruses, bioluminescence monitoring, and intraperitoneal delivery in icodextrinMichelle Lockley, Mario Fernandez, Yaohe Wang, et al.Human Gene Therapy|August 7, 2002
Cells as vehicles for cancer gene therapy: the missing link between targeted vectors and systemic delivery?Kevin Harrington, Luis Alvarez-Vallina, Marka Crittenden, et al.Cancers|May 14, 2025
The Combination of Oncolytic Virus and Antibody Blockade of TGF-β Enhances the Efficacy of αvβ6-Targeting CAR T Cells Against Pancreatic Cancer in an Immunocompetent ModelZuoyi Zhao, Lauren C Cutmore, Renato B Baleeiro, et al.Cancer Research|April 19, 2005
High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patientsDale Vimalachandran, William Greenhalf, Christopher Thompson, et al.Journal for Immunotherapy of Cancer|January 27, 2021
A systemically deliverable Vaccinia virus with increased capacity for intertumoral and intratumoral spread effectively treats pancreatic cancerGiulia Marelli, Louisa S Chard Dunmall, Ming Yuan, et al.Journal for Immunotherapy of Cancer|August 16, 2023
Personalized neoantigen viro-immunotherapy platform for triple-negative breast cancerRenato Brito Baleeiro, Peng Liu, Louisa S Chard Dunmall, et al.Journal for Immunotherapy of Cancer|March 29, 2020
A new oncolytic Vacciniavirus augments antitumor immune responses to prevent tumor recurrence and metastasis after surgeryJahangir Ahmed, Louisa S Chard, Ming Yuan, et al.JAMA Oncology|September 2, 2016
Arginine Deprivation With Pegylated Arginine Deiminase in Patients With Argininosuccinate Synthetase 1-Deficient Malignant Pleural Mesothelioma: A Randomized Clinical TrialPeter W Szlosarek, Jeremy P Steele, Luke Nolan, et al.Pageof 1